SIMA CAHSAI: Open Payments
NPI 1356059216 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$888 in 38 payments from 14 companies in 2025. Trend: 2023 $562 · 2024 $896 · 2025 $888
Food & beverage: $888
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $228 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $167 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 8 | $102 |
| Inspire Medical Systems, Inc. | 2 | $83 |
| Boston Scientific Corporation | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| Amgen Inc. | 2 | $38 |
| LANTHEUS MEDICAL IMAGING, INC. | 1 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| HEARTFLOW, INC. | 1 | $28 |
Products named: LEQVIO, Kerendia, LifeVest, INSPIRE, WATCHMAN FLX, VERQUVO, Repatha, DEFINITY.
Industry payments across CA — which companies pay providers there.
